Dishman Carbogen Amcis Limited
Overview
Dishman Carbogen Amcis Limited is a global outsourcing partner for pharmaceutical companies offering a portfolio of integrated, multiservice contract development and manufacturing services (CDMO) across the drug lifecycle. The company operates as a public entity and is focused on high-potency development projects and niche market therapeutics.
API / Drug Master Files
Dishman Carbogen Amcis Limited holds 12 active (23 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- CETRIMIDEActive2020-11-02
- INDIGOTINDISULFONATE SODIUM USPActive2018-06-14
- DIACETONE FRUCTOSEActive2018-05-23
- BUPIVACAINEActive2017-12-22
- ISOSULFAN BLUEActive2016-12-06
- SODIUM PICOSULFATEActive2013-10-17
- ROPIVACAINE HYDROCHLORIDE MONOHYDRATEActive2011-11-14
- PRALIDOXIME CHLORIDEActive2008-02-04
- BUPIVACAINE HYDROCHLORIDEActive2007-10-18
- BISACODYLActive2007-04-24
- CETYLPYRIDINIUM CHLORIDEActive2007-03-16
- EPROSARTAN MESYLATEActive2005-03-07
- CHOLECALCIFEROL USPInactive2019-12-17
- LEVOBUPIVACAINEInactive2019-08-20
- CHLORHEXIDINE GLUCONATE SOLUTIONInactive2018-10-21
Showing 15 of 23 Drug Master Files.
FDA compliance signals
1 FDA enforcement record linked to this company.
- eu_noncompliance2020-04-20
EU GMP Statement of Non-Compliance
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.